Antibacterial Nanoparticles Therapeutic (ANT) Study

Award NoticeNo Set AsideAwarded

This federal contract opportunity has been awarded to on August 19, 2026.

Award Information

This solicitation resulted in an award to for approximately $295,460 on August 19, 2026. Similar contracts are typically issued by DEPT OF DEFENSE under 541713 (Research and Development in Nanotechnology).

Award Number
HT9426-26-C-E018
Award Amount
$295,460
Award Date
August 19, 2026

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Set-aside for No Set Aside businesses
  • Work to be performed in FORT DETRICK, MD
  • Industry: Research and Development in Nanotechnology

Contract Details

Notice ID
HT9426-26-C-E018
Opportunity Type
Award Notice
Sub-Agency
DEFENSE HEALTH AGENCY (DHA)
Office
DEFENSE HEALTH AGENCY
Posted Date
Wednesday, August 19, 2026
Response Deadline
Not specified
PSC Code
AN13
Set-Aside
No Set Aside
Place of Performance
FORT DETRICK, MD, 21702
Status
Active

Description

The Walter Reed Army Institute of Research (WRAIR), Bacterial Diseases Branch (BDB)seeks to conduct a Research and Development (R&D) study to test innovative antibacterial nanoparticles with phage-mimicking properties (PhANPs) against combat relevant multi-drug resistant (MDR) strains of Pseudomonas (P.) aeruginosa, bacterial pathogen to cause hard to treat and even deadly infections in service members after battlefield injuries. A RFI was posted pm sam.govs GPE on 18 March 2026 and closed on 1 April 2026, three responses were received, and the Contracting Officers Representative preformed a technical evaluation, two of the responses were deemed not capable for the requirement, and one, The University of Notre Dame, was deemed capable for the requirement. A Notice of Intent was posted on s

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for research and development in nanotechnology with a set-aside for No Set Aside businesses in FORT DETRICK, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.